Distribution of histone deacetylases 1–11 in the rat brain (original) (raw)

• Acharya M. R., Sparreboom, A., Venitz J., and Figg W. D. (2005) Rational development of histone deacetylase inhibitors as anticancer agents: a review. Mol. Pharmacol. 68, 917–932.
  Article PubMed CAS Google Scholar
• Ajamian F., Suuronen T., Salminen A., and Reeben M. (2003) Upregulation of class II histone deacetylases mRNA during neural differentiation of cultured rat hippocampal progenitor cells. neurosci. Lett. 346, 57–60.
  Article PubMed CAS Google Scholar
• Alarcon J. M., Malleret G., Touzani K., et al. (2004) Chromatin acetylation memory, and LTP are impaired in CBP+/−mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 42, 947–959.
  Article PubMed CAS Google Scholar
• Araki T., Sasaki Y., and Milbrandt J. (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305, 1010–1013.
  Article PubMed CAS Google Scholar
• Bereshchenko O. R., Gu W., and Dalla-Favera R. (2002) Acetylation inactivates the transcriptional repressor BCL6. Nat. Genet. 32, 606–613.
  Article PubMed CAS Google Scholar
• Bolger T. A. and Yao T. P. (2005) Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. J. Neurosci. 25, 9544–9553.
  Article PubMed CAS Google Scholar
• Bradbury C. A., Khanim G. L., Hayden R., et al. (2005). Histone deacetylase in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia 19, 1751–1759.
  Article PubMed CAS Google Scholar
• Broide R. S., Trembleau A., Ellison J. A., et al. (2004) Standardized quantitative in situ hybridization using radioactive oligonucleotide probes for detecting relative levels of mRNA transcripts verified by real-time PCR. Brain Res. 1000 211–222.
  Article PubMed CAS Google Scholar
• Camelo S., Iglesias A. H., Hwang D., et al. (2005) Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol. 164, 10–21.
  Article PubMed CAS Google Scholar
• Chiurazzi P., Pomponi M. G., Pietrobono R., Bakker C. E., Neri G., and Oostra B. A. (1999) Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum. Mol. Genet. 8, 2317–2323.
  Article PubMed CAS Google Scholar
• Choi J. H., Oh S. W., Kang M. S., et al. (2001) Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn. J. Cancer Res. 92, 1300–1304.
  PubMed CAS Google Scholar
• Choi J. H., Kwon H. J., Yoon B. I., et al. (2005) Trichostatin A attenuates airway inflammation in mouse asthma model. Clin. Exp. Allergy 35, 89–96.
  Article PubMed CAS Google Scholar
• Dokmanovic M. and Marks P. A. (2005) Prospects: histone deacetylase inhibitors. J. Cell. Biochem. 96, 293–304.
  Article PubMed CAS Google Scholar
• Emerich D. F., Skinner S. J., Borlongan C. V., Vasconcellos A. V., and Thanos C. G. (2005) The choroid plexus in the rise, fall and repair of the brain. Bioessays 27, 262–274.
  Article PubMed CAS Google Scholar
• Ferrante R. J., Kublius J. K., Lee J., et al. (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci. 23, 9418–9427.
  PubMed CAS Google Scholar
• Franklin K. B. J. and Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates, Academic Press, San Diego, CA.
  Google Scholar
• Gao L., Cueto M. A., Asselbergs F., and Atadja P. (2002) Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J. Biol. Chem. 277, 24,748–25,755.
  Google Scholar
• Gardian G., Yang L., Cleren C., Calingasan N. Y., Klivenyi P., and Beal M. F. (2005) Neuroprotective effects of phenylbutyrate in the N171-82O transgenic mouse model of Huntington's disease. J. Biol. Chem. 280, 556–563.
  PubMed CAS Google Scholar
• Gardian G., Browne S. E., Choi D. K., et al. (2004) Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity. Neuromol. Med. 5, 235–241.
  Article CAS Google Scholar
• Gregoretti I. V., Lee Y. M., and Goodson H. V. (2004) Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J. Mol. Biol. 338, 17–31.
  Article PubMed CAS Google Scholar
• Haggarty S. J., Koeller K. M., Wong J. C., Grozinger C. M., and Schreiber, S. L. (2003) Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc. Natl. Acad. Sci. U. S. A. 100, 4389–4394.
  Article PubMed CAS Google Scholar
• Hao Y., Creson T., Zhang L., et al. (2004) Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J. Neurosci. 24, 6590–6599.
  Article PubMed CAS Google Scholar
• Hockly E., Richon V. M., Woodman B., et al. (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 100, 2041–2046.
  Article PubMed CAS Google Scholar
• Hoshino M., Tagawa K., Okuda T., et al. (2003) Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein. J. Neurochem., 87, 257–267.
  Article PubMed CAS Google Scholar
• Ito, K., Caramori G., Lim S., et al. (2002) Expression and activity of histone deacetylases in human asthmatic airways. Am. J. Respir. Crit. Care Med. 166, 392–396.
  Article PubMed Google Scholar
• Ito K. K., Ito M., Elliott W. M., et al. (2005) Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N. Engl. J. Med. 352, 1967–1976.
  Article PubMed CAS Google Scholar
• Jeong M. R., Hashimoto, R., Senatorov V. V., et al. (2003) Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEBS Lett. 542, 74–78.
  Article PubMed CAS Google Scholar
• Johnstone R. W. (2002) Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1, 287–299.
  Article PubMed CAS Google Scholar
• Kawaguchi Y., Kovacs J. J., McLaruin A., Vance J. M., Ito, A., and Yao T. P. (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115, 727–738.
  Article PubMed CAS Google Scholar
• Kelly W. K., O'Connor O. A., Krug L. M., et al. (2005) Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer. J. Clin. Oncol. 23, 3923–3931.
  Article PubMed CAS Google Scholar
• Kouraklis G. and Theocharis S. (2002) Histone deacetylase inhibitors and anticancer therapy. Curr. Med. Chem. Anti-Cancer Agents 2, 477–484.
  Article CAS Google Scholar
• Langley B., Gensert J. M., Beal M. F., and Ratan R. R. (2005) Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as noveland broadly effective neuroprotective agents. Curr. Drug Targets CNS Neurol. Disord. 4, 41–50.
  Article PubMed CAS Google Scholar
• Lin A. Y. (2005) Histone deacetylase activity and COPD, author reply. N. Engl. J. Med. 353, 528, 529.
  Article PubMed CAS Google Scholar
• Marks P. A., Miller T., and Richon V. M. (2003) Histone deacetylases. Curr. Opin. Pharmacol. 3, 344–351.
  Article PubMed CAS Google Scholar
• Marks P. A., Richon V. M., Miller T., and Kelley W. K. (2004) Histone deacetylase inhibitors. Adv. Cancer Res. 91, 137–168.
  Article PubMed CAS Google Scholar
• Moradei O., Maroun C. R., Paquin I., and Vaisburg A. (2005) Histone deacetylase inhibitors: latest developments, trends and prospects. Curr. Med. Chem. Anti-Cancer Agents 5, 529–560.
  Article CAS Google Scholar
• Naruse Y., Oh-hashi K., Iijima N., Naruse M., Yoshioka H., and Tanaka M. (2004) Circadian and light-induced transcription of clock gene Per1 depends on histone acetylation and deacetylation. Mol. Cell. Biol. 24, 6278–6287.
  Article PubMed CAS Google Scholar
• Panteleeva I., Rouaux C., Larmet Y., Boutillier S., Loeffler J. P., and Boutillier A. L. (2004) HDAC-3 participates in the repression of e2f-dependent gene transcription in primary differentiated neurons. Ann. N. Y. Acad. Sci. 1030, 656–660.
  Article PubMed CAS Google Scholar
• Ren M., Leng Y., Jeong M., Leeds P. R., and Chuang D. M. (2004) Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J. Neurochem. 89, 1358–1367.
  Article PubMed CAS Google Scholar
• Richon V. M., Zhou X., Rifkind R. A., and Marks P. A. (2001) Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers. Blood Cell Mol. Dis. 27, 260–264.
  Article CAS Google Scholar
• Robyr D., Suka Y., Xenarios I., et al. (2002) Microarray deacetylation maps determine genome-wide functions for yeast histone deacetylases Cell 109, 437–446.
  Article PubMed CAS Google Scholar
• Roth S.Y., Denu J. M., and Allis C. D. (2001) Histone acetyltransferases. Annu. Rev. Biochem. 70, 81–120.
  Article PubMed CAS Google Scholar
• Saha R. N. and Pahan K. (2005) HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 39, 539–550.
  Google Scholar
• Shabbeer S., and Carducci M. A. (2005) Focus on deacetylation for therapeutic benefit. Investigational Drugs 8, 144–154.
  CAS Google Scholar
• Shen S., Li J., and Casaccia-Bonnefil P. (2005) Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J. Cell. Biol. 169, 577–589.
  Article PubMed CAS Google Scholar
• Vaghefi H., and Neet K. E. (2004) Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation. Oncogene 23, 8078–8087.
  Article PubMed CAS Google Scholar
• Voelter-Mahlknecht S., Ho A. D., and Mahlknecht, U. (2005) Chromosomal organization and locolization of the novel class IV human histone deacetylase 11 gene. Int. J. Mol. Med. 16, 589–598.
  PubMed CAS Google Scholar
• Yamaguchi M., Tonou-Fujimori N., Komori A., et al. (2005) Histone deacetylase 1 regulates retinal neurogenesis in zebrafish by suppressing Wnt and Notch signaling pathways. Development 132, 3027–3043.
  Article PubMed CAS Google Scholar
• Yu X., Guo Z. S., Marcu M. G., et al. (2002) Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. J. Natl. Cancer Inst. 94, 504–513.
  PubMed CAS Google Scholar